| 5A/5A | 5A/6A | 6A/6A | χ2 | P | 5A | 6A | χ2 | p |
Non-CAD (n = 405) | 34 (8.4%) | 154 (38%) | 217 (53.6%) |
|
| 222 (27.4%) | 588 (72.6%) |
|
|
CAD patients (n = 395) | 52 (13.2%) | 85 (21.5%) | 258 (65.4%) | 27.1 | <0.001 | 189 (23.9%) | 601 (76.1%) | 2.5 | NS |
MI CAD (n = 238) | 21 (8.8%) | 46 (19.3%) | 171 (71.8%) |
|
| 88 (18.5%) | 388 (81.5%) |
|
|
Non-MI CAD (n = 157) | 31 (19.7%) | 39 (24.8%) | 87 (55.4%) | 13.8 | <0.001 | 101 (32.2%) | 213 (67.8%) | 19.4 | <0.001 |